PORCN and neoplasm: Therefore, many human tumor cells may not have responded to PORCN treatment because of the inappropriate or overexpressed levels of Wnt pathway activities or the involvement of other interacting pathways induced by aberrant Wnt signalling and accumulated mutations in these cells.